TITLE

Kidney failure and diabetes. Diagnostic inertia

AUTHOR(S)
García, R. Blanco; López, J. J. Bravo; Pérez, A.; Plaza, M. Moreiras
PUB. DATE
December 2010
SOURCE
Nefrologia;2010, Vol. 30 Issue 6, p712
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study of a 62-year-old man with a history of arterial hypertension, duodenal ulcer and type 2 diabetes mellitus (DM). He was admitted to the internal medicine department with pyelonephritis with acute kidney failure (KF). The article discusses the most common cause of KF which is DM, but this pathology is not only aetiology in diabetic patients which is presented with renal failure.
ACCESSION #
56947139

 

Related Articles

  • Peroxisome Proliferator--Activated Receptor-γ2 Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes. Herrmann, Stefan-Martin; Ringel, Jens; Ji-Guang Wang; Wang, Ji-Guang; Staessen, Jan A.; Brand, Eva // Diabetes;Aug2002, Vol. 51 Issue 8, p2653 

    The Pro12Ala polymorphism of the gene encoding the peroxisome proliferator-activated receptor (PPAR)-2 has recently been shown to be associated with type 2 diabetes. In the present analysis, we investigated whether PPAR-2 Pro12Ala was associated with microvascular complications of type 2...

  • South-Asian Type 2 Diabetic Patients Have Higher Incidence and Faster Progression of Renal Disease Compared With Dutch-European Diabetic Patients. Shaw, Prataap K. Chandie; Baboe, Fazil; van Es, Leendert A.; van der Vijver, J. Carel; van de Ree, Marcel A.; de Jonge, Niels; Rabelink, Ton J. // Diabetes Care;Jun2006, Vol. 29 Issue 6, p1383 

    The article discusses a study in South-Asian and Dutch-European type 2 diabetic patients to compare differences in the incidence of microalbuminuria and progression of renal failure between both ethnic groups. The study explained the discrepancy between the reported eight-times higher prevalence...

  • Hypertension Update: Targeting Albuminuria for Cardiorenal Protection in Diabetic and Hypertensive Kidney Disease. Hart, Peter D.; Bakris, George L. // Kidney;Jul/Aug2006, Vol. 15 Issue 4, p149 

    The article focuses on the importance of albuminuria as a therapeutic agent for cardiovascular diseases and renoprotection. Some studies suggested that microalbuminuria is associated with increased mortality in type 2 diabetes. Macroalbuminuria is a known independent risk market for progressive...

  • Metformin.  // Reactions Weekly;6/24/2006, Issue 1107, p16 

    The article presents case reports of patients, aged 55 to 83 years, who developed severe lactic acidosis and acute renal failure during treatment with metformin for type 2 diabetes mellitus. It references a study by M. J. Nyirenda et al, published in the April 2006 issue of the "Diabetic...

  • Atorvastatin Reduces the Risk of Major Cardiovascular Events in Patients With Diabetes and Impaired Renal Function in the Collaborative Atorvastatin Diabetes Study (CARDS). Colhoun, Helen M.; Szarek, Michael; Demicco, David A.; Nell, Andrew W.; Betteridge, John; Hitman, Graham A.; Durrington, Paul N.; Fuller, John H. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA139 

    There are few published trial data on the effectiveness of lipid lowering in diabetic patients with impaired renal function. CARDS was a randomised placebo-controlled trial of atorvastatin 10 mg daily versus placebo in 2838 type 2 diabetic patients with no prior cardiovascular disease. Estimated...

  • Pharmacokinetics of the Long-Acting Human GLP-1 Analogue Liraglutide in Subjects with Renal Impairment. Jacobsen, Lisbeth V.; Hindsberger, Charlotte; Robson, Richard; Zdravkovic, Milan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA137 

    Liraglutide is a long-acting GLP-1 analogue to be used as a once-daily treatment in patients with type 2 diabetes. The effect of renal impairment on the pharmacokinetics (PK) of liraglutide was investigated in a single centre, open label trial. Six subjects with normal renal function (creatinine...

  • Importancia de la hemodiafiltración precoz en el tratamiento de la acidosis láctica asociada a la administración de metformina. Baró-Serra, Anna; Guasch-Aragay, Bernat; Martín-Alemany, Nàdia; Sirvent, Josep M.; Vallès-Prats, Martí // Nefrologia;2012, Vol. 32 Issue 5, p664 

    Metformin is a drug widely used in type 2 diabetic patients. The metformin-associated lactic acidosis (ALAM) in diabetic patients is rare but can be serious. However, the relationship between metformin and lactic acidosis has been controversial. We present seven cases of patients with ALAM who...

  • Development of Type 2 Diabetes among People Participating in a Program To Promote Healthy Behaviors. Smith, G. Davey; Bracha, Y.; Svendsen, K.H.; Neaton, J.D.; Haffner, S.M.; Kuller, L.H. // Annals of Internal Medicine;3/1/2005, Vol. 142 Issue 5, pI17 

    This article focuses on a study of the development of type 2 diabetes among people who are participating in a program to promote health behaviors. Type 2 diabetes interferes with the body's ability to store energy from food. The result is high levels of blood sugar. Over time, high blood sugar...

  • Metformin.  // Reactions Weekly;12/1/2007, Issue 1180, p26 

    The article describes the case of an 82-year-old man who developed lactic acidosis and acute renal failure following cardiac catheterisation and during treatment with metformin for type 2 diabetes mellitus. The patient had a history of arterial hypertension and revascularised ischaemic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics